2-구획 인공 모세혈관 모델을 이용한 Pseudomonas aeruginosa 임상균주에 대한 Panipenem의 효과 = Efficacy of Panipenem versus Imipenem against Clinical Isolate of Pseudomonas aeruginosa in a Two-Compartment Artificial Capillary Model

참고문헌 (Reference)

1 "항균제의 약동학/약력학" 17 : 99-113, 1999

2 "시험관내 역동모델을 이용한 Klebsiella pneumoniae에 대한 ceftriaxone과 amikacin의 병용요법" 7 : 40-48, 1999

3 "Two compartment kinetic model with multiple artificial capillary units" 15 : 131-137, 1985

4 "The use of antibiotics, a clinical review of antibacterial, antifungal and antiviral drugs 5th ed" Butterworth-Heinemann 232-233, 1997

5 "Recent developments in carbapenems" 11 : 529-544, 2002

6 "Rapid bactericidal activities of carbapenems against Pseudomonas aeruginosa in simulating human plasma concentrations" 55 : 187-195, 2002

7 "Pharmacokinetics of panipenem/betamipron" 39 : 227-235, 1991

8 "Pharmacodynamics of levofloxacin and ciprofloxacin against Streptococcus pneumoniae" 43 : 79-86, 1999

9 "Performance standards for antimicrobial susceptibility testing; 12th informational supplement" 100-112, 2002

10 "Panipenem을 포함한 carbapenem 계열 항생제의 몇 가지 임상균주에 대한 시험관내 항균력" 35 : 91-98, 2003

11 "Panipenem/betamipron" 63 : 913-925, 2003

12 "Overview of a new carbapenem,panipenem/betamipron" 20 : 241-245, 1994

13 "Laboratory and clinical studies on panipenem/betamipron" shige kusa (shige kusa): 3 449-454, 1991

14 "Killing of Pseumomonas aeruginosa during continuous and intermittent infusion of ceftazidime in an in vitro pharmacokinetic model" 38 : 931-936, 1994

15 "Ion-exchange chromatography of amino acids in sweat collected from healthy subjects during sauna bathing" 20 : 1305-1312, 1974

16 "Increase in susceptibility of Pseudomonas aeruginosa to carbapenem antibiotics in low-amino-acid media" 35 : 529-532, 1991

17 "In vitro antimicrobial activity of carbapenem antibiotics against Pseudomonas aeruginosa, measured using a low-concentration Mueller- Hinton Agar culture medium" 52 : 449-457, 1999

18 "In vitro antibotic pharmacodynamic models, Antimicrobial pharmacodyanamics in theory and clinical practice" Marcel Dekker, Inc. 41-65, 2002

19 "Efficacy of intermittent versus continuous administration of netilmicin in a two-compartment in vitro model" 27 : 343-349, 1985

20 "Efficacies of vancomycin,arbekacin,and gentamicin alone or in combination against methicillin-resistant Staphylococcus aureus in an in vitro infective endocarditis model" 47 : 3768-3773, 2003

21 "Effect of basic amino acids on susceptibility to carbapenems in clinical Pseudomonas aeruginosa isolates" 293 : 191-197, 2003

22 "Decreases of the susceptibility to low molecular weight beta-lactam antibiotics in imipenem-resistant Pseudomonas aeruginosa mutants:role of outer membrane protein D2 in their diffusion" 25 : 191-198, 1990

23 "Comparative in vitro activity of carbapenem antibiotics against respiratory pathogens isolated in recent years" 5 : 171-175, 1999

24 "Cefepime- aztreonam:a unique double β-lactam combination for Pseudomonas aeruginosa" 42 : 1610-1619, 1998

25 "CS-976(panipenem/betamipron)a new carbapenem antibiotic" 43 : 1-73, 1991

26 "C-terminal region of Pseudomonas aeruginosa outer membrane porin OprD modulates susceptibility to meropenem" 45 : 1780-1787, 2001

27 "Antibacterial activity of panipenem" a new carbapenem antibiotic 3 1-13, 1991

28 "Activity of the carbapenem panipenem and role of the OprD(D2)protein in its diffusion through the Pseudomonas aeruginosa outer membrane" 37 : 322-327, 1993